Viking Therapeutics (VKTX) Total Non-Current Liabilities (2014 - 2026)
Viking Therapeutics' Total Non-Current Liabilities was $3.93 million in Q2 2026, up 857.3% from $410,000 a year earlier.
Powered by 
Analysis
Viking Therapeutics (VKTX) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends
At the end of FY2024, Total Non-Current Liabilities at Viking Therapeutics came in at $630,000, down 32.7% from FY2023.
- Total Non-Current Liabilities shows a five-year compound annual growth rate of 11.8% (FY2019 to FY2024).
- In earlier years, Total Non-Current Liabilities was $936,000 in FY2023 (-25.7%), $1.26 million in FY2022 and $29,000 in FY2020 (-91.9%).
- The Q2 2026 figure marks the highest quarterly Total Non-Current Liabilities since Q1 2017.
- Compared with a year earlier, Total Non-Current Liabilities was higher in 1 of the last six quarters, with growth averaging 108.9%.
- The best year-over-year quarter for Total Non-Current Liabilities over five years was Q2 2026 (growth of 857.3%); the worst was Q3 2025 (a decline of 57.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.99 Bn | 1,102.58 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 615.70 Bn | 534.23 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 501.05 Bn | 474.16 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.20 Bn | 234.88 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 235.55 Bn | 190.95 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 190.64 Bn | 164.84 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 169.29 Bn | 115.93 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Viking Therapeutics | 3.11 Bn | 585.90 Mn | - | 3.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.93 Mn |
| Sep 30, 2025 | 318,000.00 |
| Jun 30, 2025 | 410,000.00 |
| Mar 31, 2025 | 502,000.00 |
| Dec 31, 2024 | 630,000.00 |
| Sep 30, 2024 | 755,000.00 |
| Jun 30, 2024 | 766,000.00 |
| Mar 31, 2024 | 852,000.00 |
| Dec 31, 2023 | 936,000.00 |
| Sep 30, 2023 | 1.02 Mn |
| Jun 30, 2023 | 1.10 Mn |
| Mar 31, 2023 | 1.18 Mn |
| Dec 31, 2022 | 1.26 Mn |
| Sep 30, 2022 | 1.34 Mn |
| Jun 30, 2022 | 1.41 Mn |
| Mar 31, 2022 | 1.49 Mn |
| Dec 31, 2020 | 29,000.00 |
| Sep 30, 2020 | 115,000.00 |
| Jun 30, 2020 | 198,000.00 |
| Mar 31, 2020 | 279,000.00 |
API Access
Viking Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();